Kmpharmaceutical Co (XKRX:225430) Cyclically Adjusted Book per Share: ₩7,870.58 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XKRX:225430 Kmpharmaceutical Co Ltd XKRX:225430
54 GF Score
Price ₩682.00
GF Value ₩3,687.04
Valuation Possible Value Trap
! 5 Warning Signs
View Full Analysis

What is Kmpharmaceutical Co Cyclically Adjusted Book per Share?

Kmpharmaceutical Co XKRX:225430 +29.90% 54 Cyclically Adjusted Book per Share is ₩7,870.58 as of Jun. 2026. GuruFocus rates XKRX:225430 with a GF Score™ of 54/100 and a GF Value™ of ₩3,687.04 (Possible Value Trap). The stock has 5 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Kmpharmaceutical Co's adjusted book value per share for the three months ended in Jun. 2026 was ₩4,782.158. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is ₩7,870.58 for the trailing ten years ended in Jun. 2026.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

As of today (2026-09-14), Kmpharmaceutical Co's current stock price is ₩682.00. Kmpharmaceutical Co's Cyclically Adjusted Book per Share for the quarter that ended in Jun. 2026 was ₩7,870.58. Kmpharmaceutical Co's Cyclically Adjusted PB Ratio of today is 0.09.

During the past 11 years, the highest Cyclically Adjusted PB Ratio of Kmpharmaceutical Co was 0.50. The lowest was 0.09. And the median was 0.32.


Kmpharmaceutical Co  (XKRX:225430) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Kmpharmaceutical Co's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=682.00/7870.58
=0.09

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 11 years, the highest Cyclically Adjusted PB Ratio of Kmpharmaceutical Co was 0.50. The lowest was 0.09. And the median was 0.32.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Kmpharmaceutical Co Cyclically Adjusted Book per Share Related Terms


Kmpharmaceutical Co Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for Kmpharmaceutical Co's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Kmpharmaceutical Co Cyclically Adjusted Book per Share Chart

Kmpharmaceutical Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 8,023.57

Kmpharmaceutical Co Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 8,137.69 8,023.57 7,951.93 7,870.58

XKRX:225430 vs BLK, BX, KKR: Cyclically Adjusted Book per Share Comparison

For the Asset Management subindustry, Kmpharmaceutical Co's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Kmpharmaceutical Co Cyclically Adjusted PB Ratio vs Asset Management Industry

For the Asset Management industry and Financial Services sector, Kmpharmaceutical Co's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Kmpharmaceutical Co's Cyclically Adjusted PB Ratio falls into.


XKRX:225430
54GF Score
Kmpharmaceutical Co Ltd XKRX:225430
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Kmpharmaceutical Co Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Kmpharmaceutical Co's adjusted Book Value per Share data for the three months ended in Jun. 2026 was:

Adj_Book= Book Value per Share /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=4782.158/126.4904*126.4904
=4,782.158

Current CPI (Jun. 2026) = 126.4904.

Kmpharmaceutical Co Quarterly Data

Book Value per Share CPI Adj_Book
201609 8,941.735 101.461 11,147.548
201612 8,943.362 101.561 11,138.588
201703 8,951.585 102.851 11,009.071
201706 8,928.438 102.611 11,006.212
201709 8,935.866 103.491 10,921.788
201712 15,308.266 102.991 18,801.181
201803 8,969.807 104.101 10,898.999
201806 9,042.687 104.130 10,984.441
201809 5,695.234 105.651 6,818.637
201812 5,700.508 104.351 6,909.964
201903 5,730.505 104.491 6,937.005
201906 5,656.155 104.881 6,821.541
201909 5,603.641 105.200 6,737.688
201912 5,381.310 105.121 6,475.225
202003 5,473.835 105.354 6,571.998
202006 5,520.457 105.112 6,643.258
202009 5,477.442 106.198 6,524.101
202012 7,311.063 105.765 8,743.684
202103 7,314.390 107.357 8,617.961
202106 7,336.040 107.579 8,625.681
202109 7,263.069 108.759 8,447.180
202112 7,155.481 109.676 8,252.456
202203 7,218.512 111.848 8,163.512
202206 7,132.395 114.072 7,908.839
202209 6,882.830 114.715 7,589.327
202212 6,513.887 115.179 7,153.585
202303 6,510.404 116.507 7,068.252
202306 6,538.863 117.182 7,058.274
202309 6,447.299 118.964 6,855.218
202312 6,361.592 118.837 6,771.289
202403 6,269.034 120.123 6,601.328
202406 6,048.023 120.007 6,374.753
202409 5,877.649 120.861 6,151.405
202412 5,848.146 121.135 6,106.683
202503 5,700.339 122.590 5,881.705
202506 5,527.576 122.611 5,702.463
202509 5,345.498 123.402 5,479.294
202512 5,068.387 123.939 5,172.712
202603 4,918.817 125.236 4,968.085
202606 4,782.158 126.490 4,782.158

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of ₩7,870.58 mean?
Kmpharmaceutical Co (XKRX:225430) has a Cyclically Adjusted Book per Share of ₩7,870.58 as of Jun. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Kmpharmaceutical Co and its competitors.
Is Kmpharmaceutical Co's Cyclically Adjusted Book per Share too high?
Kmpharmaceutical Co's current Cyclically Adjusted Book per Share is ₩7,870.58. Overall, Kmpharmaceutical Co has a GF Score™ of 54/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Kmpharmaceutical Co's Cyclically Adjusted Book per Share compare to BLK and BX?
Kmpharmaceutical Co's Cyclically Adjusted Book per Share of ₩7,870.58 can be compared against companies in the Asset Management industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for an Asset Management company?
A good Cyclically Adjusted Book per Share depends on the Asset Management industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Kmpharmaceutical Co and its competitors. Kmpharmaceutical Co's current Cyclically Adjusted Book per Share is ₩7,870.58. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kmpharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Kmpharmaceutical Co (XKRX:225430) is currently considered Possible Value Trap. The stock's GF Value™ is ₩3,687.04, compared to a current price of ₩682.00 — trading 81.5% below its estimated fair value. The current Cyclically Adjusted Book per Share is ₩7,870.58. Kmpharmaceutical Co's overall GF Score™ is 54/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For Kmpharmaceutical Co (XKRX:225430), the current Cyclically Adjusted Book per Share is ₩7,870.58 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Kmpharmaceutical Co (XKRX:225430) Overvalued in 2026?

Based on GuruFocus' analysis, Kmpharmaceutical Co stock appears to be undervalued. The current stock price of ₩682.00 is trading 81.5% below its estimated GF Value™ of ₩3,687.04. GuruFocus considers Kmpharmaceutical Co to be Possible Value Trap.

Key valuation signals for XKRX:225430:

  • Cyclically Adjusted Book per Share: ₩7,870.58
  • GF Value™: ₩3,687.04 vs. price of ₩682.00 (81.5% below fair value)
  • GF Score™: 54/100 with 5 warning signs

No single metric tells the full story. See the XKRX:225430 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Kmpharmaceutical Co Business Description

Address Six road-dong, Yeongdeungpo-gu, Triple-floor building 6, Seoul International Finance 11 (dong), Seoul, KOR, 07330
Kmpharmaceutical Co Ltd, formerly IBKS No.3 Special Purpose Acquisition Co is engaged in auxiliary to financial service activities.
54GF Score

Get the complete analysis for XKRX:225430

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₩682.00
Price
₩3,687.04
GF Value